TGF-β signaling in endometrial cancer

Piestrzeniewicz-Ulanska, D., McGuinness, D.H. and Yeaman, G.R. (2008) TGF-β signaling in endometrial cancer. In: Jakowlew, S.B. (ed.) Transforming Growth Factor-β in Cancer Therapy. Series: Cancer Drug Discovery and Development, 2. Humana Press: Totowa, NJ, pp. 63-78. ISBN 9781588297150 (doi: 10.1007/978-1-59745-293-9_5)

This is the latest version of this item.

Full text not currently available from Enlighten.

Abstract

The members of the transforming growth factor-β (TGF-β) superfamily are involved in the regulation of many crucial biological processes including cell proliferation, differentiation, ECM remodelling, metastasis and apoptosis of different cell types. On the other hand, components of the TGF-β signaling cascade are considered classic tumor-suppressors that can play multiple roles in carcinogenesis, acting as tumor suppressors during early stage disease and as tumor promoters at later stages of tumorigenesis. Loss of TGF-β-induced growth inhibition, which is characteristic for many types of cancers, has been associated with disruption and/or dysregulation of the TGF-β pathway, which may facilitate invasion, metastasis, and angiogenesis.

Item Type:Book Sections
Status:Published
Glasgow Author(s) Enlighten ID:Mcguinness, Dr David and McGuinness, Dr Dagmara
Authors: Piestrzeniewicz-Ulanska, D., McGuinness, D.H., and Yeaman, G.R.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Publisher:Humana Press
ISBN:9781588297150
Related URLs:

Available Versions of this Item

University Staff: Request a correction | Enlighten Editors: Update this record